Health Care: Drugs

Exelixis Inc (EXEL: NASDAQ)

$4.19 0.16 | 3.97%
08/01/14 - 04:00 PM ET
Latest Dividend:0
Latest Dividend Yield:0%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
EXELSector Avg.S&P 500
n/a028.9
Price Performance History (% change):
3 Mo1 Yr3 Yr
13.8418-20.3557-47.6623
GROWTH12 Mo3 YrCAGR
Revenue-34-0.83-0.44
Net Income1.650
EPS0.56n/a
Earnings for EXEL:
EBITDA-199.00
REVENUE31.34M
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $-0.39 $-0.39 $-1.55 $-1.36
Number of Analysts 5 5 6 6
High Estimate $-0.37 $-0.37 $-1.49 $-1.02
Low Estimate $-0.40 $-0.39 $-1.58 $-1.66
Prior Year $-0.34 $-0.36 $-1.32 $-1.55
Growth Rate (Year over Year) -13.53% -7.22% -17.55% 12.46%

Portfolios with EXEL

Latest EXEL Headlines from TheStreet

More Financial News for EXEL

Press Releases for EXEL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter